VKTX - Viking Therapeutics gains on additional data for NASH drug
2024-06-04 08:07:00 ET
More on Viking Therapeutics
- What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner
- Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired
- Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcript
- SA Asks: Which weight-loss stocks should investors be watching?
- Viking falls after Roche’s obesity drug data; RayJay upgrades (update)